Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group.

J Clin Oncol 2002 Aug;20(16):3431-7

Vanderbilt Cancer Center, Nashville, TN, USA.

Purpose: This Children's Cancer Group group-wide phase II trial evaluated the efficacy and toxicity of two chemotherapy arms administered before hyperfractionated external-beam radiotherapy (HFEBRT).

Patients And Methods: Thirty-two patients with newly diagnosed brainstem gliomas were randomly assigned to regimen A and 31 to regimen B. Regimen A comprised three courses of carboplatin, etoposide, and vincristine; regimen B comprised cisplatin, etoposide, cyclophosphamide, and vincristine. Both arms included granulocyte colony-stimulating factor. Patients were evaluated by magnetic resonance imaging after induction chemotherapy and HFEBRT at a dose of 72 Gy.

Results: Ten percent +/- 5% of regimen A patients objectively responded to chemotherapy. For combined induction and radiotherapy, 27% +/- 9% of patients improved. The neuroradiographic response rate for regimen B was 19% +/- 8% for chemotherapy and 23% +/- 9% after HFEBRT. Response rates were not statistically significant between regimens after induction or chemotherapy/HFEBRT. Event-free survival was 17% +/- 5% (estimate +/- SE) at 1 year and 6% +/- 3% at 2 years. Survival was significantly longer among patients who responded to chemotherapy (P <.05). Among patients who received regimen A induction, grades 3 and 4 leukopenia were observed in 50% to 65%, with one toxicity-related death. For regimen B, severe leukopenia occurred in 86% to 100%, with febrile neutropenia in 48% to 60% per course.

Conclusion: Neither chemotherapy regimen meaningfully improved response rate, event-free survival, or overall survival relative to previous series of patients with brainstem gliomas who received radiotherapy with or without chemotherapy.

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2002.04.109DOI Listing
August 2002
40 Reads

Publication Analysis

Top Keywords

regimen regimen
8
cancer group
8
responded chemotherapy
8
regimen comprised
8
children's cancer
8
+/-
7
regimen
6
patients
5
chemotherapy
5
induction chemotherapy
4
imaging induction
4
dose gyresults
4
hfebrt dose
4
chemotherapy hfebrt
4
gyresults ten
4
percent +/-
4
objectively responded
4
courses carboplatin
4
patients objectively
4
regimen patients
4

Similar Publications